ZYTIGA 500mg 60TABS.

Product Description:

ZYTIGA 500mg 60TABS contains the active ingredient Abiraterone, used in the treatment of metastatic castration-resistant prostate cancer (mCRPC). It works by inhibiting the enzyme CYP17A1, which is responsible for producing testosterone. This reduces the production of testosterone, a hormone that fuels the growth of prostate cancer cells.

Benefits:

Reduces testosterone production by inhibiting CYP17A1.
Helps treat metastatic castration-resistant prostate cancer.
Enhances the effects of hormonal therapy and helps prevent cancer progression.
Reduces tumor size and improves the patient's overall condition.

How to Use:

Take two 500mg tablets of ZYTIGA daily (total 1000mg), with or without food, as directed by your doctor.
It should be taken with Prednisone or Prednisolone to reduce the risk of side effects related to the reduction of testosterone levels.
Take the medication at the same time each day for optimal results.

Warnings:

Consult a doctor before starting treatment if you have a history of liver disease, uncontrolled high blood pressure, or kidney problems.
ZYTIGA should not be used during pregnancy or breastfeeding.
Regular monitoring of blood pressure, liver enzymes, and electrolytes (especially potassium levels) is necessary during treatment.
Avoid using ZYTIGA if you have an allergy to any of its ingredients.
Additional Notes:

It is essential to follow the prescribed dosage and medical advice carefully to ensure the effectiveness of ZYTIGA and minimize any potential side effects.